nach oben

Erschienen in:

2024 | OriginalPaper | Buchkapitel

15. Point of Care CRISPR/Cas Biosensing Technology: A Well Promising Management Strategies Towards the Possible COVID-19 Resurgence Caused by Hospital Contaminants

verfasst von : Animesh Pattnaik, Madhusmita Barik, Swayamprabha Sahoo, Rukmini Mishra, Jatindra Nath Mohanty

Erschienen in: Impact of COVID-19 Waste on Environmental Pollution and Its Sustainable Management

Verlag: Springer Nature Switzerland

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

The Covid-19 pandemic caused by SARS-CoV-2 is highly transmissible and has significant public health concerns worldwide. It mainly spreads through respiratory droplets but there is a possibility of transmission through contaminated surfaces, especially in hospital settings, which has raised widespread concerns. CRISPR/Cas biosensing technology has potential in hospital settings to develop a portable device that can detect viral RNA on surfaces, equipment, and in the air. This can help identify areas that require more thorough cleaning, disinfection, and enable rapid isolation of infected patients. The chapter discusses the possibility of SARS-CoV-2 infection through hospital-contaminated surfaces, equipment, and air, and the management of it through an on-site testing system using CRISPR-based biosensors. The chapter discusses the application of CRISPR-based biosensors, including specialized identification components like Cas9, Cas12, and Cas13, which can be used with various readout techniques such as fluorescence, colorimetry, and lateral flow assay. The technology can be used in medical facilities to create a portable tool that can detect viral RNA on surfaces, tools, and the air. With further development and implementation, it can be a valuable tool for improving hospital safety and controlling the spread of the virus.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 340 Zeitschriften

aus folgenden Fachgebieten:

Bauwesen + Immobilien
Business IT + Informatik
Finance + Banking
Management + Führung
Marketing + Vertrieb
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Vorheriges Kapitel Microplastic Pollution: Occurrence, Sources and Impact of COVID-19 Generated Waste

Nächstes Kapitel Solid Waste Management During and After the COVID-19 Outbreak: Possibilities, Difficulties and Approaches

Abid S, Jie Z (2021) Molecular mechanisms of SARS-CoV-2 pathogenesis, immune responses, and therapeutics. Signal Transduct Target Ther 6(1):1–22

Ackerman CM, Myhrvold C, Thakku SG, Freije CA, Metsky HC, Yang DK, Ye SH, Boehm CK, Kosoko-Thoroddsen T-SF, Kehe J et al (2020) Massively multiplexed nucleic acid detection with Cas13. Nature 582:277–282CrossRef

Ademiluyi AO, Oyeniran OO, Oboh BO (2020) Molecular modeling studies of therapeutic potentials of phytochemicals from African medicinal plants against Covid-19. Bioinformation 16(10):787–803

Ali N, Rampazzo R, Costa ADT, Krieger MA (2017) Current nucleic acid extraction methods and their implications to point-of-care diagnostics. BioMed Res. Int. 2017:9306564CrossRef

Ali Z, Aman R, Mahas A, Rao GS, Tehseen M, Marsic T, Salunke R, Subudhi AK, Hala SM, Hamdan SM et al (2020) ISCAN: an RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2. Virus Res 288:198129CrossRef

Asadi S, Bouvier N, Wexler AS, Ristenpart WD (2020) The coronavirus pandemic and aerosols: does Covid-19 transmit via expiratory particles? Aerosol Sci Technol 54(6):635–638

Arizti-Sanz J, Freije CA, Stanton AC, Boehm CK, Petros BA, Siddiqui S, Shaw BM, Adams G, Kosoko-Thoroddsen TF, Kemball ME, et al (2020) Integrated sample inactivation, amplification, and Cas13-based detection of SARS-CoV-2. bioRxiv 2020 28:119131, Preprint. Update in Nat Commun 2020 11:5921.

Baldasano JM (2020) Covid-19 lockdown effects on air quality by NO₂ in the cities of Barcelona and Madrid (Spain). Sci Total Environ 741:140353. https://doi.org/10.1016/j.scitotenv.2020.140353

Bando T, Takei R, Mutoh Y, Sasano H, Yamano Y, Yokoyama T, Matsuda T, Kataoka K, Kimura T, Kondoh Y (2022) Acute exacerbation of idiopathic pulmonary fibrosis after SARS-CoV-2 vaccination. Eur Respir J 59(3)

Bao M, Chen Q, Xu Z, Jensen EC, Liu C, Waitkus JT, Yuan X, He Q, Qin P, Du K (2021) Challenges and opportunities for clustered regularly interspaced short palindromic repeats based molecular biosensing. ACS Sens. 6:2497–2522

Batista AC, Pacheco LG (2018) Detecting pathogens with Zinc-Finger, TALE and CRISPR-based programmable nucleic acid binding proteins. J Microbiol Methods 152:98–104CrossRef

Batista AC, Ferreira GNM, Franco OL, Migliolo L (2018) Modified nucleic acid binding and cleavage proteins as next-generation tools for point-of-care diagnostics of infectious diseases. Expert Rev Mol Diagn 18(4):319–329. https://doi.org/10.1080/14737159.2018.1446186CrossRef

Behera BC, Mishra RR, Thatoi H (2021) Recent biotechnological tools for diagnosis of corona virus disease: a review. Biotechnol Prog 37:e3078CrossRef

Berlanga FA, Liu L, Nielsen PV, Jensen RL, Costa A, Olmedo I, de Adana MR (2020) Influence of the geometry of the airways on the characterization of exhalation flows. Comparison between two different airway complexity levels performing two different breathing functions. Sustain Cities Soc 53:101874

Bhalla N, Jolly P, Formisano N, Estrela P (2016) Introduction to biosensors. Essays Biochem 60:1–8

Bhattacharyya RP, Thakku SG, Hung DT (2018) Harnessing CRISPR effectors for infectious disease diagnostics. ACS Infect Dis 4:1278–1282CrossRef

Birgand G, Peiffer-Smadja N, Fournier S, Kerneis S, Lescure FX, Lucet JC (2020) Assessment of air contamination by SARS-CoV-2 in hospital settings. JAMA Network Open 3(12):e2033232

Bonini A, Poma N, Vivaldi F, Biagini D, Bottai D, Tavanti A, Di Francesco F (2021a) A label-free impedance biosensing assay based on CRISPR/Cas12a collateral activity for bacterial DNA detection. J Pharm Biomed Anal 204:114268

Bonini A, Poma N, Vivaldi F, Kirchhain A, Salvo P, Bottai D, Tavanti A, Di Francesco F (2021b) Advances in biosensing: the CRISPR/Cas system as a new powerful tool for the detection of nucleic acids. J Pharm Biomed Anal 192:113645

Bourouiba L (2020) Turbulent gas clouds and respiratory pathogen emissions: potential implications for reducing transmission of Covid-19. JAMA 323(18):1837–1838

Brennecke A, Villar L, Wang Z et al (2020) Is inhaled furosemide a potential therapeutic for Covid-19? Am J Med Sci 360(3):216–221. https://doi.org/10.1016/j.amjms.2020.05.044CrossRef

Broughton JP, Deng X, Yu G, Fasching CL, Servellita V, Singh J, Miao X, Streithorst JA, Granados A, Sotomayor-Gonzalez A et al (2020) CRISPR–Cas12-based detection of SARS-CoV-2. Nat Biotechnol 38:870–874

Brouns SJJ, Jore MM, Lundgren M, Westra ER, Slijkhuis RJH, Snijders APL et al (2008) Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321(5891):960–964CrossRef

Bruch R, Urban GA, Dincer C (2019) CRISPR/Cas powered multiplexed biosensing. Trends Biotechnol 37:791–792CrossRef

Capoor MR, Parida A (2021) Current perspectives of biomedical waste management in context of Covid-19. Indian J Med Microbiol 39:171–178. https://doi.org/10.1016/j.ijmmb.2021.03.003CrossRef

Chen M, Luo D (2020) A CRISPR path to cutting-edge materials. N Engl J Med 382:85–88CrossRef

Chen Y, Shi Y, Chen Y, Yang Z, Wu H, Zhou Z, Li J, Ping J, He L, Shen H et al (2020) Contamination-free visual detection of SARS-CoV-2 with CRISPR/Cas12a: a promising method in the point-of-care detection. Biosens Bioelectron 169:112642CrossRef

Chen W, Chen CL, Cao Q, Chiu CH (2022) Time course and epidemiological features of Covid-19 resurgence due to cold-chain food or packaging contamination. Biomed J 45(3):432–438CrossRef

Chhikara BS, Rathi B, Singh J, Poonam FN (2020) Corona virus SARS-CoV-2 disease Covid-19: infection, prevention and clinical advances of the prospective chemical drug therapeutics: array. Chem Biol Lett 7(1):63–72

Cho S, Shin J, Cho B-K (2018) Applications of CRISPR/Cas system to bacterial metabolic engineering. Int J Mol Sci 19:1089CrossRef

Colaneri M, Seminari E, Piralla A, Zuccaro V, Di Filippo A, Baldanti F, Bruno R, Mondelli MU, Brunetti E, Di Matteo A, Maiocchi L (2020) Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy. J Hosp Infect 105(3):474–476

Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK et al (2020) Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance 25(3):2000045

Dai Y, Wu Y, Liu G, Gooding JJ (2020) CRISPR mediated biosensing toward understanding cellular biology and point-of-care diagnosis. Angew Chem Int Ed 59:20754–20766

Dai M, Li H, Yan N, Huang J, Zhao L, Xu S, Wu J, Jiang S, Pan C, Liao M (2021) Long-term survival of SARS-CoV-2 on salmon as a source for international transmission. J Infect Dis 223(3):537–539CrossRef

Dancer SJ (2021) Reducing the risk of Covid-19 transmission in hospitals: focus on additional infection control strategies. Surg Infect (larchmt) 39(11):752–758

Dancer SJ, Li Y, Hart A, Tang JW, Jones DL (2021) What is the risk of acquiring SARS-CoV-2 from the use of public toilets? Sci Total Environ 792:148341

Das AP, Kumar PS, Swain S (2014) Recent advances in biosensor based endotoxin detection. Biosense Bioelectron 51:62–75CrossRef

Das AP, Ghosh S, Mohanty S, Sukla LB (2015a) Consequences of manganese compounds: a review. Toxicol Environ Chem 96(7):981–997CrossRef

Das A, Bal B, Mahapatra P (2015b) Chromogenic biosensors for pathogen detection. In: Biological and pharmaceutical applications of nanomaterials. CRC Press, Boca Raton, pp 273–288. https://doi.org/10.1201/b18654-15

Das AP, Ghosh S, Mohanty S, Sukla LB (2015c) Advances in manganese pollution and its bioremediation. In: Environmental microbial biotechnology. soil biology. Springer, Singapore

Das AP, Bal B, Mahapatra PS (2015d) Chromogenic biosensors for pathogen detection. In: Biological and Pharmaceutical Applications of Nanomaterial. CRC press, Taylor and Francis, Boca Raton

Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, Pirzada ZA, Charpentier E (2011) CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471(7340):602–607. https://doi.org/10.1038/nature09886

Dey S, Tripathy B, Kumar MS, Das AP (2023) Ecotoxicological consequences of manganese mining pollutants and their biological remediation. Environ Chem Ecotoxicol. https://doi.org/10.1016/J.ENCECO.2023.01.001

Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, Yatoo MI (2020a) Coronavirus disease 2019-Covid-19. Clin Microbiol Rev 33(4):e00028-e120CrossRef

Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, Singh KP, Chaicumpa W, Bonilla-Aldana DK, Rodriguez-Morales AJ (2020b) Coronavirus disease 2019–Covid-19. Clin Microbiol Rev 33(4):e00028-20CrossRef

Ding X, Bin P, Wu W, Chang Y, Zhu G (2020) Tryptophan metabolism, regulatory t cells, and inflammatory bowel disease: a mini review. Mediat Inflamm 2020:9706140CrossRef

Dong D, Ren K, Qiu X, Zheng J, Guo M, Guan X et al (2016) The crystal structure of Cpf1 in complex with CRISPR RNA. Nature 532(7600):522–526. https://doi.org/10.1038/nature17944CrossRef

Dong D, Zhao Y, Guo M, Shi Y, Yang Z, Huang D et al (2017) The structure of the Cpf1 endonuclease R-loop complex reveals the mechanism of target DNA strand cleavage. Cell Res 27(12):1525–1532. https://doi.org/10.1038/cr.2017.139CrossRef

Doroshenko A (2021) The combined effect of vaccination and nonpharmaceutical public health interventions—ending the Covid-19 pandemic. JAMA Netw Open 4(6):e2111675CrossRef

Du H, Shi S, Liu W et al (2019) Hydrophobic-force-driven adsorption of bisphenol A from aqueous solution by polyethylene glycol diacrylate hydrogel microsphere. Environ Sci Pollut Res 26:22362–22371. https://doi.org/10.1007/s11356-019-05557-5CrossRef

Gootenberg JS, Abudayyeh OO, Lee JW, Essletzbichler P, Dy AJ, Joung J, Verdine V, Donghia N, Daringer NM, Freije CA et al (2017) Nucleic acid detection with CRISPR-Cas13a/C2c2. Science 356:438–442CrossRef

Gootenberg JS et al (2018) Nucleic acid detection with CRISPR-Cas13a/C2c2. Science 360(6387):439–444CrossRef

Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y (2020a) The origin, transmission and clinical therapies on coronavirus disease 2019 (Covid-19) outbreak–an update on the status. Mil Med Res 7:1–0

Guo L, Liu W, Li Z, Li L (2020b) An adaptive sliding mode control strategy for the heading control of autonomous underwater vehicles. In: Proceedings of the Global Oceans 2020: Singapore—U.S. Gulf Coast, Biloxi, MS, USA, 5–30 October 2020, pp 1–4

Hinge VR, Chavhan RL, Kale SP, Suprasanna P, Kadam US (2021) Engineering resistance against viruses in field crops using CRISPRCas9. Curr Genom 22:214–231CrossRef

Hou T, Zeng W, Yang M, Chen W, Ren L, Ai J, Wu J, Liao Y, Gou X, Li Y et al (2020) Development and evaluation of a rapid CRISPR-based diagnostic for Covid-19. PLoS Pathog 16:e1008705CrossRef

Hu B, Guo H, Zhou P, Shi Z-L (2021) Characteristics of SARS-CoV-2 and Covid-19. Nat Rev Microbiol 19(3):141–154CrossRef

Johansson H et al (2021) Auto-RPA-fluorescence, a new diagnostic method for rapid detection of SARS-CoV-2. Sci Rep 11(1):1–9

Johnston M, Ates HC, Glatz RT, Mohsenin H, Schmachtenberg R, Göppert N, Huzly D, Urban GA, Weber W, Dincer C (2022) Multiplexed biosensor for point-of-care Covid-19 monitoring: CRISPR-powered unamplified RNA diagnostics and protein-based therapeutic drug management. Mater Today 1(61):129–138CrossRef

Joung J, Ladha A, Saito M, Segel M, Bruneau R, Huang MW, Kim N-G, Yu X, Li J, Walker BD et al (2020) Point-of-care testing for Covid-19 using SHERLOCK diagnostics. medRxiv

Kachwala MJ, Smith CW, Nandu N, Yigit MV (2021) Reprogrammable gel electrophoresis detection assay using CRISPR-Cas12a and hybridization chain reaction. Anal Chem 93:1934–1938CrossRef

Katzmeier CM, Sukumar S, Kerin T, Yager P (2019a) Rapid point-of-care diagnostics for infectious diseases: where are we now? Diagnostics 9(3):118. https://doi.org/10.3390/diagnostics9030118CrossRef

Katzmeier F, Aufinger L, Dupin A, Quintero J, Lenz M, Bauer LG, Klumpe S, Sherpa D, Dürr B, Honemann M et al (2019b) A low-cost fluorescence reader for in vitro transcription and nucleic acid detection with Cas13a. PLoS ONE 14:e0220091CrossRef

Keeley AJ, Evans C, Colton H, Ankcorn M, Cope A, Bennett T, Giri P, de Silva TI, Raza M (2020) Roll-out of SARSCoV-2 testing for healthcare workers at a large NHS Foundation Trust in the United Kingdom, March 2020. Eurosurveillance 25(14):2000433

Kellner MJ, Koob JG, Gootenberg JS, Abudayyeh OO, Zhang F, Sabeti PC (2019) SHERLOCK: nucleic acid detection with CRISPR nucleases. Nat Protoc 14(10):2986–3012

Kellner MJ, Lajoie MJ, Song L, Wang J (2020) CRISPR-based detection of SARS-CoV-2: a review of diagnostic approaches. Genes 11(7):803

Khan MA, Hashim H (2020) The effect of Covid-19 on tourism and hospitality industry in Malaysia, resurgence in the post-pandemic Era: a conceptual criterion. Int J Tourism Hosp Rev 7(2):54–62CrossRef

Kim J, Campbell AS, de Ávila BE-F, Wang J (2019) Wearable biosensors for healthcare monitoring. Nat Biotechnol 37:389–406CrossRef

Kim S, Ji S, Koh HR (2021) CRISPR as a diagnostic tool. Biomolecules 11:1162CrossRef

Knowlton KU (2019) Pathogenesis of SARS-CoV-2 induced cardiacinjury from the perspective of the virus. J Mol Cell Cardiol 147:12–17. https://doi.org/10.1016/j.yjmcc.2020.08.002CrossRef

Kostyusheva A, Brezgin S, Babin Y, Vasilyeva I, Glebe D, Kostyushev D, Chulanov V (2022) CRISPR-Cas systems for diagnosing infectious diseases. Methods 203:431–446CrossRef

Kumar S, Tripathy S, Jyoti A, Singh SG (2018) Recent advances in biosensors for diagnosis and detection of sepsis: a comprehensive review. Biosens Bioelectron 124–125:205–215

Kumar V, Singh SB, Singh S (2020) Covid-19: environment concern and impact of Indian medicinal system. J Environ Chem Eng 8:104144CrossRef

Kumaran A, Jude Serpes N, Gupta T, James A, Sharma A, Kumar D, Nagraik R, Kumar V, Pandey S (2023) Advancements in CRISPR-based biosensing for next-gen point of care diagnostic application. Biosensors 13(2):202CrossRef

Kumari V, Mehta K, Choudhary R (2020) Covid-19 outbreak and decreased hospitalisation of pregnant women in labour. Lancet Glob Health 8(9):e1116–e1177

Lai S, Ruktanonchai NW, Carioli A, Ruktanonchai CW, Floyd JR, Prosper O, Zhang C, Du X, Yang W, Tatem AJ (2020) Assessing the effect of global travel and contact reductions to mitigate the Covid-19 pandemic and resurgence. MedRxiv 19:2020–2106

Li SY, Cheng QX, Liu JK, Nie XQ, Zhao GP, Wang J (2018) CRISPR-Cas12a has both cis-and trans-cleavage activities on single-stranded DNA. Cell Res 28(4):491–493CrossRef

Li Z, Wei J, Di D, Wang X, Li C, Li B, Qiu Y, Liu K, Gu F, Tong M et al (2020) Rapid and accurate detection of African swine fever virus by DNA endonuclease-targeted CRISPR trans reporter assay. Acta Biochim Biophys Sin 52:1413–1419CrossRef

Li Z, Zhao W, Ma S, Li Z, Yao Y, Fei T (2021) A chemical-enhanced system for CRISPR-Based nucleic acid detection. Biosens Bioelectron 192:113493CrossRef

Liu H, Wang J, Hu X, Tang X, Zhang C (2022) A rapid and high-throughput Helicobacter pylori RPA-CRISPR/Cas12a-based nucleic acid detection system. Clin Chim Acta

Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, Wang Z, Li J, Li J, Feng C, Zhang Z (2020) Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 63:364–374

Louie RF, Tang Z, Shelby MDG, Kost GJ (2000) Point-of-care testing: millennium technology for critical care. Lab Med 31:402–408

Lucia C, Federico PB, Alejandra GC (2020) An ultrasensitive, rapid, and portable coronavirus SARS-CoV-2 sequence detection method based on CRISPR-Cas12. bioRxiv

Ma L, Peng L, Yin L, Liu G, Man S (2021) CRISPR-Cas12a-powered dual-mode biosensor for ultrasensitive and cross-validating detection of pathogenic bacteria. ACS Sens 6:2920–2927CrossRef

Makarova KS, Wolf YI, Koonin EV (2013) The basic building blocks and evolution of CRISPR–Cas systems. Biochem Mol Biol 49(4):655–669

Makarova KS, Wolf YI, Koonin EV (2015) Classification and nomenclature of CRISPR-Cas systems: where from here? F1000Research 4:1461. https://doi.org/10.12688/f1000research.7524.1

Mak GC, Cheng PK, Lau SS, Wong KK, Lau CS, Lam ET, Chan RC, Tsang DN (2020) Evaluation of rapid antigen test for detection of SARS-CoV-2 virus. J Clin Virol 129:104500

Mishra S, Rath CC, Das AP (2019) Marine microfiber pollution: a review on present status and future challenges. Mar Pollut Bull 140:188–197. https://doi.org/10.1016/J.MARPOLBUL.2019.01.039

Mishra S, Singh RP, Rath CC, Das AP (2020) Synthetic microfibers: source, transport and their remediation. J Water Process Eng 38:101612. https://doi.org/10.1016/J.JWPE.2020.101612

Mohammad N, Katkam SS, Wei Q (2022) Recent advances in CRISPR-based biosensors for point-of-care pathogen detection. CRISPR J 5(4):500–516

Mohanty M, Mohanty J, Dey S, Dutta K, Shah MP, Das AP (2024) The face mask: a tale from protection to pollution and demanding sustainable solution. Emerg Contam 10(2):100298, ISSN 2405-6650. https://doi.org/10.1016/j.emcon.2023.100298

Moon KB, Jeon JH, Choi H, Park JS, Park SJ, Lee HJ, Park JM, Cho HS, Moon JS, Oh H, Kang S (2022) Construction of SARS-CoV-2 virus-like particles in plant. Sci Rep 12(1):1005

Myhrvold C, Freije CA, Gootenberg JS, Abudayyeh OO, Metsky HC, Durbin AF, Kellner MJ, Tan AL, Paul LM, Parham LA, Garcia KF (2018) Field-deployable viral diagnostics using CRISPR-Cas13. Science 360(6387):444–448

Niazkhani Z, Pirnejad H (2018) Point-of-care testing (POCT) in healthcare: a review. J Med Syst 42(12):254

Nouri R, Jiang Y, Lian XL, Guan W (2020) Sequence-specific recognition of HIV-1 DNA with solid-state CRISPR-Cas12a-assisted nanopores (SCAN). ACS Sens 5:1273–1280CrossRef

Nouri R, Tang Z, Dong M, Liu T, Kshirsagar A, Guan W (2021) CRISPR-based detection of SARS-CoV-2: a review from sample to result. Biosens Bioelectron 178:113012CrossRef

Oran DP, Topol EJ (2020) Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann Intern Med 173(5):362–367CrossRef

Patchsung M, Jantarug K, Pattama A, Aphicho K, Suraritdechachai S, Meesawat P, Sappakhaw K, Leelahakorn N, Ruenkam T, Wongsatit T et al (2020) Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA. Nat Biomed Eng 4:1140–1149CrossRef

Patel M, Kumar R, Kishor K et al (2019) Pharmaceuticals of emerging concern in aquatic systems: chemistry, occurrence, effects, and removal methods. Chem Rev 119:3510–3673. https://doi.org/10.1021/acs.chemrev.8b00299CrossRef

Price CP (2001) Regular review: point of care testing. BMJ 322:1285–1288CrossRef

Price CP, Kricka LJ (2007) Improving healthcare accessibility through point-of-care technologies. Clin Chem 53(9):1665–1675CrossRef

Price CP, Kricka LJ, Siegelman ES (2007) Principles and practice of point-of-care testing. Am J Clin Pathol 128(3):378–383. https://doi.org/10.1309/F6UJX6M5G6E52GFJCrossRef

Qing M, Chen SL, Sun Z, Fan Y, Luo HQ, Li NB (2021) Universal and programmable rolling circle amplification-CRISPR/Cas12a-mediated immobilization-free electrochemical biosensor. Anal Chem 93:7499–7507CrossRef

Quan J, Langelier C, Kuchta A, Batson J, Teyssier N, Lyden A, Caldera S, McGeever A, Dimitrov B, King R et al (2019) FLASH: A next-generation CRISPR diagnostic for multiplexed detection of antimicrobial resistance sequences. Nucleic Acids Res 47:e83CrossRef

Rai P, Kumar BK, Deekshit VK, Karunasagar I, Karunasagar I (2021) Detection technologies and recent developments in the diagnosis of Covid-19 infection. Appl Microbiol Biotechnol 105:441–455CrossRef

Rauch JN, Valois E, Solley SC, Braig F, Lach RS, Audouard M, Ponce-Rojas JC, Costello MS, Baxter NJ, Kosik KS et al (2021) A scalable, easy-to-deploy protocol for Cas13-based detection of SARS-CoV-2 genetic material. J Clin Microbiol 59:e02402CrossRef

Ravi N, Cortade DL, Ng E, Wang SX (2020) Diagnostics for SARS-CoV-2 detection: a comprehensive review of the FDA-EUA Covid-19 testing landscape. Biosens Bioelectron 165:112454CrossRef

Safari F, Hatam G, Behbahani AB, Rezaei V, Barekati-Mowahed M, Petramfar P, Khademi F (2020) CRISPR system: a highthroughput toolbox for research and treatment of Parkinson’s disease. Cell Mol Neurobiol 40:477–493CrossRef

Saravanos GL, Hu N, Homaira N, Muscatello DJ, Jaffe A, Bartlett AW, Wood NJ, Rawlinson W, Kesson A, Lingam R, Britton PN (2022) RSV epidemiology in Australia before and during Covid-19. Pediatrics 149(2):e2021053537

Schmidt ML et al (2020) Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance 25:2000045. Erratum in Euro Surveill 2021, 26

Sharma M, Mindermann S, Rogers-Smith C, Leech G, Snodin B, Ahuja J, Sandbrink JB, Monrad JT, Altman G, Dhaliwal G, Finnveden L (2021) Understanding the effectiveness of government interventions against the resurgence of Covid-19 in Europe. Nat Commun 12(1):5820CrossRef

Shmakov S, Abudayyeh OO, Makarova KS, Wolf YI, Gootenberg JS, Semenova E et al (2015) Discovery and functional characterization of diverse class 2 CRISPR-Cas systems. Mol Cell 60(3):385–397. https://doi.org/10.1016/j.molcel.2015.10.008CrossRef

Sitjar J, Palau J, Lurz R (2021) SARS-CoV-2 and the Covid-19 pandemic: a comprehensive review on virus transmission, antigenic drift, and vaccine efficacy. Rev Med Virol 31(1):e2181

Song F, Shi N, Shan F, Zhang Z, Shen J, Lu H, Ling Y, Jiang Y, Shi Y (2020) Emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology 295(1):210–217

Van Der Oost J, Westra ER, Jackson RN, Wiedenheft B (2014) Unravelling the structural and mechanistic basis of CRISPR–Cas systems. Nat Rev Microbiol 12:479–492

van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO (2020) Aerosol and surface stability of SARS-CoV-2 as compared with SARSCoV-1. New England J Med 382(16):1564–1567

Wang L, Shen X, Wang T, Chen P, Qi N, Yin B-C, Ye B-C (2020a) A lateral flow strip combined with Cas9 nickase-triggered amplification reaction for dual food-borne pathogen detection. Biosens Bioelectron 165:112364

Wang P, Casner RG, Nair MS, Wang M, Yu J, Cerutti G, Liu L, Kwong PD, Huang Y, Shapiro L, Ho DD (2021) Increased resistance of SARS-CoV-2 variant P. 1 to antibody neutralization. Cell Host & Microbe 29(5):747–751

Wang C, Horby PW, Hayden FG, Gao GF (2020b) A novel coronavirus outbreak of global health concern. Lancet 395:470–473. Erratum in Lancet 2020, 31986257

Wu C, Chen Z, Li C, Hao Y, Tang Y, Yuan Y, Chai L, Fan T, Yu J, Ma X, Al-Hartomy OA, Wageh S, Al-Sehemi AG, Luo Z, He Y, Li J, Xie Z, Zhang H (2022) CRISPR-Cas12a-empowered electrochemical biosensor for rapid and ultrasensitive detection of SARS-CoV-2 delta variant. Nano-Micro Lett 14(1):159

Xie S, Ji Z, Suo T, Li B, Zhang X (2021) Advancing sensing technology with CRISPR: from the detection of nucleic acids to a broad range of analytes—a review. Anal Chim Acta 1185:338848CrossRef

Xiong Y, Zhang J, Yang Z, Mou Q, Ma Y, Xiong Y, Lu Y (2020) Functional DNA regulated CRISPR-Cas12a sensors for point-of-care diagnostics of non-nucleic-acid targets. J Am Chem Soc 142:207–213CrossRef

Xu J, Li Y (2020) The role and mechanism of ACE2 in SARS-CoV-2 infection. Authors 4(4):455–461

Ye G, Lin H, Chen S, Wang S, Zeng Z, Wang W, Zhang S, Rebmann T, Li Y, Pan Z, Yang Z (2020) Environmental contamination of SARS-CoV-2 in healthcare premises. J Infect 81(2):e1-5CrossRef

Yesudhas D, Srivastava A, Gromiha MM (2021) Covid-19 outbreak: history, mechanism, transmission, structural studies and therapeutics. Infection 49:199–213CrossRef

Yin K, Ding X, Li Z, Zhao H, Cooper K, Liu C (2020) Dynamic aqueous multiphase reaction system for one-pot CRISPR-Cas12a-based ultrasensitive and quantitative molecular diagnosis. Anal Chem 92:8561–8568CrossRef

Yin L, Man S, Ye S, Liu G, Ma L (2021) CRISPR-Cas based virus detection: recent advances and perspectives. Biosens Bioelectron 193:113541CrossRef

Yuan J, Mei X, Li M, Xiang J, Liang X, Li F (2021a) CRISPR-based point-of-care testing for infectious diseases: a review. Analyst 146(17):5357–5373. https://doi.org/10.1039/D1AN00924ECrossRef

Yuan M, Ding R, Chen S, Duan G (2021b) Advances in field detection based on CRISPR/Cas system. ACS Synth Biol 10:2824–2832CrossRef

Zambrano-Monserrate MA, Ruano MA, Sanchez-Alcalde L (2020) Indirect effects of Covid-19 on the environment. Sci Total Environ. https://doi.org/10.1016/j.scitotenv.2020.138813CrossRef

Zhang Y, Qian L, Wei W, Wang Y, Wang B, Lin P et al (2018) Paired design of dCas9 as a systematic platform for the detection of featured nucleic acid sequences in pathogenic strains. ACS Synth Biol 6(2):211–216CrossRef

Zhang et al (2017) Systematic platform for the detection of featured nucleic acid sequences in pathogenic strains. ACS Synth. Biol. 6:211–216CrossRef

Zhou R, Li Y, Dong T, Tang Y, Li F (2020) A sequence-specific plasmonic loop-mediated isothermal amplification assay with orthogonal color readouts enabled by CRISPR Cas12a. Chem Commun 56:3536–3538CrossRef

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382(8):727–733

Titel: Point of Care CRISPR/Cas Biosensing Technology: A Well Promising Management Strategies Towards the Possible COVID-19 Resurgence Caused by Hospital Contaminants
verfasst von: Animesh Pattnaik
Madhusmita Barik
Swayamprabha Sahoo
Rukmini Mishra
Jatindra Nath Mohanty
Verlag: Springer Nature Switzerland
Buch: Impact of COVID-19 Waste on Environmental Pollution and Its Sustainable Management
Print ISBN: 978-3-031-50839-4

Electronic ISBN: 978-3-031-50840-0

Copyright-Jahr: 2024
DOI: https://doi.org/10.1007/978-3-031-50840-0_15

Springer Professional

Abstract

Bitte loggen Sie sich ein, um Zugang zu Ihrer Lizenz zu erhalten.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Technik"

Springer Professional "Wirtschaft"